DJIA 16,875.54 85.35 0.51%
NASDAQ 4,781.29 32.93 0.69%
S&P 500 1,989.78 9.86 0.50%
market minute promo


146.97 5.75 (4.07%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $147.15 4.20%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $142.65
Previous Close $141.22
Daily Range $140.24 - $148.22
52-Week Range $127.67 - $181.81
Market Cap $111.4B
P/E Ratio 18.70
Dividend (Yield) $3.16 (2.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 6,299,769
Average Daily Volume 4,474,464
Current FY EPS $9.74




Drug Makers

Amgen (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary Rss Feed

Cholesterol Busters Will Be Cheaper but Remain Top Sellers

Express Scripts has negotiated lower prices for next-generation cholesterol drugs, but spending on them will remain next year.

Infinity (INFI) Updates on Duvelisib and IPI-549 on R&D Day

Stock Market News for October 07, 2015

3 Health Care Stocks Nudging The Sector Higher

Premarket Biotech Digest: Anavex Uplisting, Discount On PCSK9 Inhibitors, Exact Sciences Plunges

Amgen Turning the Tables on 'Generic' Competition

With nine biosimilars in development, Amgen could offset its own losses.

Wall Street Breakfast: Crude Heads To The $50s

Merck's (MRK) All-Oral Ribavirin-Free HCV Data Published

Baxalta, Momenta Begin Pivotal Study on Biosimilar of Humira

Amgen Announces Repatha™ Co-Preferred Position on Express Scripts National Formulary

See More AMGN News...

AMGN's Top Competitors

AMGN $146.97 (4.07%)
Current stock: AMGN
GILD $99.86 (2.38%)
Current stock: GILD
CELG $116.48 (3.82%)
Current stock: CELG
$0.00 (0.00%)
Current stock: